*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C530 - Malignant neoplasm of endocervix - as a primary diagnosis code | C530 - Malignant neoplasm of endocervix - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.06 | |
| Readmission Rate (%) | 23.9 | |
| Unplanned Readmission Rate (%) | 11.64 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 740: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 744: D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 741: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 734: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 755: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 7,925 | ||||
| Total Hospitalizations with ICD C530 - Malignant neoplasm of endocervix | 77 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C530 - Malignant neoplasm of endocervix in DRG | 18.97 | ||||
| Avg LOS at DRG | 3.83 | ||||
| Avg LOS with ICD C530 - Malignant neoplasm of endocervix | 4.26 | ||||
| Readmission Rate at DRG | 13.1 | ||||
| Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | 21.62 | ||||
| Unplanned Readmission Rate at DRG | 8.56 | ||||
| Unplanned Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Total Medicare payments at DRG | $91,519,981 | ||||
| Total Medicare payments with ICD C530 - Malignant neoplasm of endocervix | $1,000,633 | ||||
| Total Medicare payment per Day at DRG | $3,014 | ||||
| Total Medicare payment per Day with ICD C530 - Malignant neoplasm of endocervix | $3,051 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,548 | ||||
| Total Medicare payment per Hospitalization with ICD C530 - Malignant neoplasm of endocervix | $12,995 | ||||
| Total Medicare Charges at DRG | $541,370,281 | ||||
| Total Medicare Charges with ICD C530 - Malignant neoplasm of endocervix | $5,113,118 | ||||
| Avg Charges at DRG | $68,312 | ||||
| Avg Charges with ICD C530 - Malignant neoplasm of endocervix | $66,404 | ||||
| Mortality Rate at DRG | 0.16 | ||||
| Mortality Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| SNF Discharge Rate at DRG | 10.86 | ||||
| SNF Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Home Discharge Rate at DRG | 70.46 | ||||
| Home Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | 76.62 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 735: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 754: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 745: D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 739: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 749: OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,320 | ||||
| Total Hospitalizations with ICD C530 - Malignant neoplasm of endocervix | 29 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C530 - Malignant neoplasm of endocervix in DRG | 7.14 | ||||
| Avg LOS at DRG | 1.98 | ||||
| Avg LOS with ICD C530 - Malignant neoplasm of endocervix | 1.69 | ||||
| Readmission Rate at DRG | 7.08 | ||||
| Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Unplanned Readmission Rate at DRG | 4.29 | ||||
| Unplanned Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Total Medicare payments at DRG | $18,395,597 | ||||
| Total Medicare payments with ICD C530 - Malignant neoplasm of endocervix | $233,081 | ||||
| Total Medicare payment per Day at DRG | $3,997 | ||||
| Total Medicare payment per Day with ICD C530 - Malignant neoplasm of endocervix | $4,757 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,929 | ||||
| Total Medicare payment per Hospitalization with ICD C530 - Malignant neoplasm of endocervix | $8,037 | ||||
| Total Medicare Charges at DRG | $127,931,264 | ||||
| Total Medicare Charges with ICD C530 - Malignant neoplasm of endocervix | $1,673,272 | ||||
| Avg Charges at DRG | $55,143 | ||||
| Avg Charges with ICD C530 - Malignant neoplasm of endocervix | $57,699 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| SNF Discharge Rate at DRG | 3.88 | ||||
| SNF Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Home Discharge Rate at DRG | 85.91 | ||||
| Home Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | 89.66 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 740: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 744: D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 741: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 755: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 734: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 7,925 | ||||
| Total Hospitalizations with ICD C530 - Malignant neoplasm of endocervix | 93 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD C530 - Malignant neoplasm of endocervix in DRG | 10.34 | ||||
| Avg LOS at DRG | 3.83 | ||||
| Avg LOS with ICD C530 - Malignant neoplasm of endocervix | 4.22 | ||||
| Readmission Rate at DRG | 13.1 | ||||
| Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | 18.89 | ||||
| Unplanned Readmission Rate at DRG | 8.56 | ||||
| Unplanned Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Total Medicare payments at DRG | $91,519,981 | ||||
| Total Medicare payments with ICD C530 - Malignant neoplasm of endocervix | $1,188,564 | ||||
| Total Medicare payment per Day at DRG | $3,014 | ||||
| Total Medicare payment per Day with ICD C530 - Malignant neoplasm of endocervix | $3,032 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,548 | ||||
| Total Medicare payment per Hospitalization with ICD C530 - Malignant neoplasm of endocervix | $12,780 | ||||
| Total Medicare Charges at DRG | $541,370,281 | ||||
| Total Medicare Charges with ICD C530 - Malignant neoplasm of endocervix | $6,511,942 | ||||
| Avg Charges at DRG | $68,312 | ||||
| Avg Charges with ICD C530 - Malignant neoplasm of endocervix | $70,021 | ||||
| Mortality Rate at DRG | 0.16 | ||||
| Mortality Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| SNF Discharge Rate at DRG | 10.86 | ||||
| SNF Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Home Discharge Rate at DRG | 70.46 | ||||
| Home Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | 75.27 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 735: PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 754: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 745: D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 739: UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 2,320 | ||||
| Total Hospitalizations with ICD C530 - Malignant neoplasm of endocervix | 34 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C530 - Malignant neoplasm of endocervix in DRG | 3.78 | ||||
| Avg LOS at DRG | 1.98 | ||||
| Avg LOS with ICD C530 - Malignant neoplasm of endocervix | 1.71 | ||||
| Readmission Rate at DRG | 7.08 | ||||
| Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Unplanned Readmission Rate at DRG | 4.29 | ||||
| Unplanned Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Total Medicare payments at DRG | $18,395,597 | ||||
| Total Medicare payments with ICD C530 - Malignant neoplasm of endocervix | $301,730 | ||||
| Total Medicare payment per Day at DRG | $3,997 | ||||
| Total Medicare payment per Day with ICD C530 - Malignant neoplasm of endocervix | $5,202 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,929 | ||||
| Total Medicare payment per Hospitalization with ICD C530 - Malignant neoplasm of endocervix | $8,874 | ||||
| Total Medicare Charges at DRG | $127,931,264 | ||||
| Total Medicare Charges with ICD C530 - Malignant neoplasm of endocervix | $2,166,099 | ||||
| Avg Charges at DRG | $55,143 | ||||
| Avg Charges with ICD C530 - Malignant neoplasm of endocervix | $63,709 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| SNF Discharge Rate at DRG | 3.88 | ||||
| SNF Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Home Discharge Rate at DRG | 85.91 | ||||
| Home Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | 85.29 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 749: OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 269,064 | ||||
| Total Hospitalizations with ICD C530 - Malignant neoplasm of endocervix | 14 | ||||
| DRG Share of Total Hospitalizations | 0.82 | ||||
| % of Total ICD C530 - Malignant neoplasm of endocervix in DRG | 1.56 | ||||
| Avg LOS at DRG | 13.18 | ||||
| Avg LOS with ICD C530 - Malignant neoplasm of endocervix | 17.79 | ||||
| Readmission Rate at DRG | 37.51 | ||||
| Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Unplanned Readmission Rate at DRG | 18.15 | ||||
| Unplanned Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Total Medicare payments at DRG | $9,344,186,034 | ||||
| Total Medicare payments with ICD C530 - Malignant neoplasm of endocervix | $515,448 | ||||
| Total Medicare payment per Day at DRG | $2,635 | ||||
| Total Medicare payment per Day with ICD C530 - Malignant neoplasm of endocervix | $2,070 | ||||
| Total Medicare payment per Hospitalization at DRG | $34,728 | ||||
| Total Medicare payment per Hospitalization with ICD C530 - Malignant neoplasm of endocervix | $36,818 | ||||
| Total Medicare Charges at DRG | $44,371,117,432 | ||||
| Total Medicare Charges with ICD C530 - Malignant neoplasm of endocervix | $2,694,417 | ||||
| Avg Charges at DRG | $164,909 | ||||
| Avg Charges with ICD C530 - Malignant neoplasm of endocervix | $192,458 | ||||
| Mortality Rate at DRG | 14.37 | ||||
| Mortality Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| SNF Discharge Rate at DRG | 31.8 | ||||
| SNF Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||||
| Home Discharge Rate at DRG | 14.61 | ||||
| Home Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 756: MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||
| Total Hospitalizations with ICD C530 - Malignant neoplasm of endocervix | 12 | ||
| DRG Share of Total Hospitalizations | 1.59 | ||
| % of Total ICD C530 - Malignant neoplasm of endocervix in DRG | 1.33 | ||
| Avg LOS at DRG | 3.14 | ||
| Avg LOS with ICD C530 - Malignant neoplasm of endocervix | 2.67 | ||
| Readmission Rate at DRG | 17.1 | ||
| Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||
| Unplanned Readmission Rate at DRG | 12.62 | ||
| Unplanned Readmission Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||
| Total Medicare payments at DRG | $2,290,151,156 | ||
| Total Medicare payments with ICD C530 - Malignant neoplasm of endocervix | $46,880 | ||
| Total Medicare payment per Day at DRG | $1,394 | ||
| Total Medicare payment per Day with ICD C530 - Malignant neoplasm of endocervix | $1,465 | ||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||
| Total Medicare payment per Hospitalization with ICD C530 - Malignant neoplasm of endocervix | $3,907 | ||
| Total Medicare Charges at DRG | $13,619,287,561 | ||
| Total Medicare Charges with ICD C530 - Malignant neoplasm of endocervix | $182,970 | ||
| Avg Charges at DRG | $26,051 | ||
| Avg Charges with ICD C530 - Malignant neoplasm of endocervix | $15,248 | ||
| Mortality Rate at DRG | 0.18 | ||
| Mortality Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||
| SNF Discharge Rate at DRG | 8.57 | ||
| SNF Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | NA | ||
| Home Discharge Rate at DRG | 72.49 | ||
| Home Discharge Rate with ICD C530 - Malignant neoplasm of endocervix | 91.67 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 19 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 16 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 12 |